Tsukita S, Furuse M: Pores in
the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 2000,149(1):13–16.PubMedCrossRef 11. Ohkubo T, Ozawa M: J The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. Cell Sci 2002,117(Pt 9):1675–1685. selleck chemical 12. Morita K, Furuse M, Fujimoto K, Tsukita S: Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci U S A 1999,96(2):511–516.PubMedCrossRef 13. Furuse M, Sasaki H, Tsukita S: Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 1999,147(4):891–903.PubMedCrossRef 14. Tsukita S: Isolation of cell-to-cell adherens junctions from rat liver. J Cell Biol 1989,108(1):31–41.PubMedCrossRef 15. Van Itallie CM, Anderson JM: Claudins and epithelial paracellular transport. Annu Rev Physiol 2006, 68:403–429.PubMedCrossRef 16. Morita K, Sasaki H, Furuse M, Tsukita S: Endothelial claudin: Claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 1999,147(1):185–194.PubMedCrossRef 17. Rahner C, Mitic LL, Anderson JM: Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology PARP inhibitor 2009,120(2):411–422.CrossRef 18. Amasheh S, Schmidt
T, Mahn M, et al.: Contribution of Claudin-5 to barrier properties in tight junctions of epithelial cells. Cell Tissue Res 2005,321(1):89–96.PubMedCrossRef 19. Wolburg H,
Wolburg-Buchholz K, Kraus J, et al.: Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis ever and human glioblastoma multiforme. Acta Neuropathol 2003,105(6):586–592.PubMed 20. Nitta T, Hata M, Gotoh S, et al.: Size-selective loosening of the blood-brain barrier in Claudin-5-deficient mice. J Cell Biol 2003,161(3):653–660.PubMedCrossRef 21. Martin TA, Watkins G, Mansel RE, Jiang WG: Hepatocyte growth factor disrupts tight junctions in human breast cancer cells. Cell Biol Int 2004,28(5):361–371.PubMedCrossRef 22. Martin TA, Watkins G, Mansel RE, Jiang WG: Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer 2004,40(18):2717–2725.PubMedCrossRef 23. Jiang WG, Davies G, Martin TA, et al.: Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy. Clin Cancer Res 2003,11(16):6012–6019.CrossRef 24. Jiang WG, Hiscox SE, Parr C, et al.: Antagonistic effect of NK4, a novel hepatocyte growth factor LY2874455 price variant, on in vitro angiogenesis of human vascular endothelial cells. Clin Cancer Res 1999,5(11):3695–3703.PubMed 25.